Cognitive-behavioural, pharmacological and psychosocial predictors of outcome during tapered discontinuation of benzodiazepine

Eighty‐six participants wishing to stop benzodiazepine and who met DSM‐IV (Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychological Association, 1994) criteria for anxiety disorder or insomnia were assessed pre‐ and post‐taper on clinical, pharmacological and psychosocia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical psychology and psychotherapy 2008-01, Vol.15 (1), p.1-14
Hauptverfasser:	O'Connor, Kieron, Marchand, André, Brousseau, Lucie, Aardema, Frederick, Mainguy, Nicole, Landry, Pierre, Savard, Pierre, Léveillé, Cathy, Lafrance, Valérie, Boivin, Sonia, Pitre, Denise, Robillard, Sophie, Bouthillier, Donald
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Anxiety Agents - adverse effects Anti-Anxiety Agents - pharmacology Anti-Anxiety Agents - therapeutic use Anxiety Anxiety Disorders - chemically induced Anxiety Disorders - drug therapy Clinical psychology Cognitive therapy Cognitive Therapy - methods Cohort Studies Diazepam - adverse effects Diazepam - pharmacology Diazepam - therapeutic use Dose-Response Relationship, Drug Drug Administration Schedule Female Follow-Up Studies Health psychology Humans Insomnia Intelligence - drug effects Longitudinal Studies Male Mental disorders Middle Aged Pharmacology Predictive Value of Tests Psychotherapy, Group - methods Self Efficacy Sleep Initiation and Maintenance Disorders - chemically induced Sleep Initiation and Maintenance Disorders - drug therapy Stress, Psychological - chemically induced Substance Withdrawal Syndrome Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!